Ischemic postconditioning: Mechanisms, comorbidities, and clinical application

Molecular and Cellular Biochemistry

Volumn 392, Issue 1-2, 2014, Pages 1-12

  Buchholz, Bruno ^a   Donato, Martín ^a   D'Annunzio, Verónica ^a   Gelpi, Ricardo J ^a  

^a University of Buenos Aires   (Argentina)

Author keywords

Ischemia; Ischemic postconditioning; Myocardial infarction

Indexed keywords

APOPTOSIS; COMORBIDITY; HEART INFARCTION; HEART INFARCTION SIZE; HEART VENTRICLE FUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; NONHUMAN; REPERFUSION INJURY; REVIEW; VASCULAR ENDOTHELIUM; ANIMAL; PATHOPHYSIOLOGY; RABBIT;

ANIMALS; APOPTOSIS; COMORBIDITY; ENDOTHELIUM, VASCULAR; ISCHEMIC POSTCONDITIONING; RABBITS;

EID: 84895774821     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2014-6     Document Type: Review

References (86)

1. Gibbons RJ, Valeti US, Araoz PA et al (2004) The quantification of infarct size. J Am Coll Cardiol 44:1533-1542 (Pubitemid 39377707)
2. Go A, Mozaffarian D, Roger V et al (2013) Heart disease and stroke statistics - 2013 update a report from the American Heart Association. Circulation 127:e6-e245. doi:10.1161/CIR.0b013e31828124ad
3. Zhao ZQ, Corvera JS, Halkos ME et al (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285:H579-H588 (Pubitemid 36885888)
4. +(ATP) channels in both normal and hypercholesterolemic rabbits. J Cardiovasc Pharmacol 49:287-292
5. Gomez L, Thibault H, Gharib A et al (2007) Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. Am J Physiol Heart Circ Physiol 293:H1654-H1661 (Pubitemid 47367212)
6. Schwartz LM, Lagranha CJ (2006) Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia - reperfusion injury in pigs. Am J Physiol Heart Circ Physiol 290:H1011-H1018
7. Skyschally A, van Caster P, Iliodromitis EK et al (2009) Ischemic postconditioning: experimental models and protocol algorithms. Basic Res Cardiol 104:469-483. doi:10.1007/s00395-009-0040-4
8. Kin H, Zhao ZQ, Sun HY et al (2004) Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62:74-85 (Pubitemid 38326813)
9. Engelman DT, Watanabe M, Engleman RM et al (1995) Constitutive nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovasc Surg 110:1047-1053
10. Schwartz BG, Kloner RA (2012) Coronary no reflow. J Mol Cell Cardiol 52:873-882. doi:10.1016/j.yjmcc.2011.06.009
11. Reffelmann T, Kloner RA (2006) The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol 101:359-372 (Pubitemid 44275869)
12. Zhao JL, Yang YJ, You SJ et al (2007) Different effects of postconditioning on myocardial no-reflow in the normal and hypercholesterolemic mini-swines. Microvasc Res 73:137-142
13. Sun HY, Wang NP, Halkos M et al (2006) Postconditioning attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathways. Apoptosis 11:1583-1593 (Pubitemid 44253675)
14. Tian Y, Zhang W, Xia D, Modi P et al (2011) Postconditioning inhibits myocardial apoptosis during prolonged reperfusion via a JAK2-STAT3-Bcl-2 pathway. J Biomed Sci 2:18-53. doi:10.1186/1423-0127-18-53
15. Kin H, Wang NP, Mykytenko J et al (2008) Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-kappa B translocation and TNF alpha release. Shock 29:761-768. doi:10.1097/SHK.0b013e31815cfd5a (Pubitemid 351769941)
16. Penna C, Perrelli MG, Tullio F et al (2013) Diazoxide postconditioning induces mitochondrial protein S-nitrosylation and a redox-sensitive mitochondrial phosphorylation/translocation of RISK elements: no role for SAFE. Basic Res Cardiol 108:371. doi:10.1007/s00395-013-0371-z
17. Anversa P, Cheng W, Liu Y et al (1998) Apoptosis and myocardial infarction. Basic Res Cardiol 93:8-12 (Pubitemid 29008240)
18. Rodríguez M, Lucchesi BR, Schaper J (2002) Apoptosis in myocardial infarction. Ann Med 34:470-479 (Pubitemid 36026778)
19. Yaoita H, Ogawa K, Maehara K et al (2000) Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction. Cardiovasc Res 45:630-641 (Pubitemid 30047129)
20. Garg S, Hofstra L, Reutelingsperger C et al (2003) Apoptosis as a therapeutic target in acutely ischemic myocardium. Curr Opin Cardiol 18:372-377 (Pubitemid 37153690)
21. Zhao ZQ, Vinten-Johansen J (2002) Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res 55:438-455
22. Cohen MV, Yang XM, Neumann T et al (2000) Favorable remodeling enhances recovery of regional myocardial function in the weeks after infarction in ischemically preconditioned hearts. Circulation 102:579-583 (Pubitemid 30639977)
23. Penna C, Tullio F, Merlino A et al (2009) Postconditioning cardioprotection against infarct size and post-ischemic systolic dysfunction is influenced by gender. Basic Res Cardiol 104:390-402. doi:10.1007/s00395-008- 0762-8
24. Shinohara G, Morita K, Nagahori R et al (2011) Ischemic postconditioning promotes left ventricular functional recovery after cardioplegic arrest in an in vivo piglet model of global ischemia reperfusion injury on cardiopulmonary bypass. J Thorac Cardiovasc Surg 142:926-932. doi:10.1016/j.jtcvs.2011.01.028
25. Sasaki H, Shimizu M, Ogawa K et al (2007) Brief ischemia - reperfusion performed after prolonged ischemia (ischemic postconditioning) can terminate reperfusion arrhythmias with no reduction of cardiac function in rats. Int Heart J 48:205-213 (Pubitemid 46592758)
26. Bell RM, Yellon DM (2012) Conditioning the whole heart-not just the cardiomyocyte. J Mol Cell Cardiol 53:24-32. doi:10.1016/j.yjmcc.2012.04.001
27. Ovize M, Baxter GF, Di Lisa F et al (2010) Postconditioning and protection from reperfusion injury: where do we stand? Cardiovasc Res 87:406-423. doi:10.1093/cvr/cvq129
28. Yang XM, Philipp S, Downey JM, Cohen MV (2005) Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 100(1):57-63 (Pubitemid 40069107)
29. Kin H, Zatta AJ, Lofye MT et al (2005) Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res 67:124-133 (Pubitemid 40798299)
30. Philipp S, Yang XM, Cui L et al (2006) Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res 70:308-314
31. Buchholz B, D'Annunzio V, Giani JF et al (2014) Ischemic postconditioning reduces infarct size trough the α-1 adrenergic receptor pathway. J Cardiovasc Pharmacol. doi:10.1097/FJC.0000000000000074
32. Inserte J, Barba I, Hernando V, Garcia-Dorado D (2009) Delayed recovery of intracellular acidosis during reperfusion prevents calpain activation and determines protection in postconditioned myocardium. Cardiovasc Res 81:116-122. doi:10.1093/cvr/cvn260
33. Schäfer C, Ladilov Y, Siegmund B, Piper HM (2000) Importance of bicarbonate transport for protection of cardiomyocytes against reoxygenation injury. Am J Physiol 278:H1457-H1463 (Pubitemid 30395555)
34. Penna C, Cappello S, Mancardi D et al (2006) Postconditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/cGMP pathway. Basic Res Cardiol 101:168-179 (Pubitemid 43250809)
35. Yang XM, Proctor JB, Cui L et al (2004) Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 44:1103-1110 (Pubitemid 39165147)
36. Fujita M, Asanuma H, Hirata A et al (2007) Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning. Am J Physiol 292:H2004-H2008. doi:10.1152/ajpheart.01051.2006 (Pubitemid 46572427)
37. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM (2004) Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 95:230-232 (Pubitemid 39056282)
38. Inserte J, Barba I, Poncelas-Nozal M et al (2011) cGMP/PKG pathway mediates myocardial postconditioning protection in rat hearts by delaying normalization of intracellular acidosis during reperfusion. J Mol Cell Cardiol 50:903-909. doi:10.1016/j.yjmcc.2011.02.013
39. Skyschally A, van Caster P, Boengler K et al (2009) Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 104:15-18. doi:10.1161/CIRCRESAHA.108.186429
40. Inserte J, Hernando V, Vilardosa U et al (2013) Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling. J Am Heart Assoc 2:e005975. doi:10.1161/JAHA.112.005975
41. Wang W, Sawicki G, Schulz R (2002) Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc Res 53(1):165-174 (Pubitemid 34020777)
42. +- ATPase in ischemia-reperfused heart may be mediated through oxidative stress. Can J Physiol Pharmacol 90:249-260. doi:10.1139/y11-128
43. Rork TH, Hadzimichalis NM, Kappil MA et al (2006) Acetaminophen attenuates peroxynitrite-activated matrix metalloproteinase-2-mediated troponin I cleavage in the isolated guinea pig myocardium. J Mol Cell Cardiol 40:553-561
44. Sawicki G, Leon H, Sawicka J et al (2005) Degradation of myosin light chain in isolated rat hearts subjected to ischemia - reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 112:544-552 (Pubitemid 41060795)
45. Sung MM, Schulz CG, Wang W et al (2007) Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury. J Mol Cell Cardiol 434:29-36
46. Giricz Z, Lalu MM, Csonka C et al (2006) Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition. J Pharmacol Exp Ther 316:154-161 (Pubitemid 41832592)
47. Donato M, D'Annunzio V, Buchholz B et al (2010) Role of matrix metalloproteinase-2 in the cardioprotective effect of ischaemic postconditioning. Exp Physiol 95:274-281. doi:10.1113/expphysiol.2009.049874
48. Halestrap AP, Clarke SJ, Javadov SA (2004) Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 61:372-385 (Pubitemid 38210145)
49. Penna C, Perrelli MG, Pagliaro P (2013) Mitochondrial pathways, permeability transition pore, and redox signaling in cardioprotection: therapeutic implications. Antioxid Redox Signal 18:556-599. doi:10.1089/ars. 2011.4459
50. Mykytenko J, Reeves JG, Kin H et al (2008) Persistent beneficial effect of postconditioning against infarct size: role of mitochondrial K (ATP) channels during reperfusion. Basic Res Cardiol 103:472-484. doi:10.1007/s00395-008-0731- 2
51. Javadov S, Karmazyn M (2007) Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem 20:1-22 (Pubitemid 46956808)
52. Gomez L, Paillard M, Thibault H et al (2008) Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 117(21):2761-2768. doi:10.1161/CIRCULATIONAHA.107.755066 (Pubitemid 351770456)
53. Hausenloy DJ, Ong SB, Yellon DM (2009) The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 104:189-202. doi:10.1007/s00395-009-0010-x
54. Argaud L, Gateau-Roesch O, Raisky O et al (2005) Postconditioning inhibits mitochondrial permeability transition. Circulation 111:194-197 (Pubitemid 40139731)
55. Bopassa JC, Ferrera R, Gateau-Roesch O et al (2006) PI3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res 69:178-185 (Pubitemid 41814821)
56. Scott MG, Richard P, Philip G et al (1999) Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. Circulation 100:1481-1492
57. Ferdinandy P, Schulz R, Baxter GF (2007) Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59:418-458
58. Messerli FH, Grossman E (2001) Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 38:E11
59. Penna C, Tullio F, Perrelli MG et al (2011) Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats. Basic Res Cardiol 106:409-420. doi:10.1007/s00395-010-0143-y
60. Fantinelli JC, Mosca SM (2007) Comparative effects of ischemic pre and postconditioning on ischemia - reperfusion injury in spontaneously hypertensive rats (SHR). Mol Cell Biochem 296:45-51
61. Iliodromitis EK, Zoga A, Vrettou A et al (2006) The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis 188:356-362 (Pubitemid 44313925)
62. Kupai K, Csonka C, Fekete V et al (2009) Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. Am J Physiol Heart Circ Physiol 297:H1729-H1735. doi:10.1152/ajpheart.00484.2009
63. Sack MN (2009) Type 2 diabetes, mitochondrial biology and the heart. J Mol Cell Cardiol 46:842-849. doi:10.1016/j.yjmcc.2009.02.001
64. Xu J, Wu Y, Song P, Zhang M, Wang S, Zou MH (2007) Proteasome-dependent degradation of guanosine 50′-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation 116:944-953 (Pubitemid 47300919)
65. Oosterlinck W, Dresselaers T, Geldhof V et al (2013) Diabetes mellitus and the metabolic syndrome do not abolish, but might reduce, the cardioprotective effect of ischemic postconditioning. J Thorac Cardiovasc Surg 145:1595-1602. doi:10.1016/j.jtcvs.2013.02.016
66. Ren JY, Song JX, Lu MY et al (2011) Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats: involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P. Regul Pept 169:49-57. doi:10.1016/j.regpep.2011.04.004
67. Miki T, Itoh T, Sunaga D et al (2012) Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning. Cardiovasc Diabetol 11:67. doi:10.1186/1475-2840-11-67
68. Sanada S, Komuro I, Kitakaze M (2011) Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol 301:H1723-H1741. doi:10.1152/ajpheart.00553.2011
69. Przyklenk K, Maynard M, Greiner DL et al (2011) Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal 14:781-790. doi:10.1089/ars.2010.3343
70. Laskey WK, Yoon S, Calzada N et al (2008) Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning. Catheter Cardiovasc Interv 72:212-220. doi:10.1002/ccd.21583
71. Staat P, Rioufol G, Piot C et al (2005) Postconditioning the human heart. Circulation 112:2143-2148 (Pubitemid 41475808)
72. Darling CE, Solari PB, Smith CS et al (2007) 'Postconditioning' the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotection. Basic Res Cardiol 102:274-278 (Pubitemid 46564075)
73. Skyschally A, Walter B, Heusch G (2013) Coronary microembolization during early reperfusion: infarct extension, but protection by ischaemic postconditioning. Eur Heart J 34:3314-3321. doi:10.1093/eurheartj/ehs434
74. Mewton N, Thibault H, Roubille F et al (2013) Postconditioning attenuates no-reflow in STEMI patients. Basic Res Cardiol 108:383. doi:10.1007/s00395-013- 0383-8
75. Heusch G (2013) Cardioprotection: chances and challenges of its translation to the clinic. Lancet 381:166-175. doi:10.1016/S0140-6736(12)60916-7
76. Ovize M, Thibault H, Przyklenk K (2013) Myocardial conditioning: opportunities for clinical translation. Circ Res 113:439-450. doi:10.1161/CIRCRESAHA.113.300764
77. Sörensson P, Rydén L, Saleh N et al (2013) Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction. BMC Cardiovasc Disord 13:22. doi:10.1186/1471-2261-13-22
78. Wei Y, Ruan L, Zhou G et al (2012) Local ischemic postconditioning during primary percutaneous coronary intervention: a meta-analysis. Cardiology 123:225-233. doi:10.1159/000342660
79. Zhou C, Yao Y, Zheng Z et al (2012) Stenting technique, gender, and age are associated with cardioprotection by ischaemic postconditioning in primary coronary intervention: a systematic review of 10 randomized trials. Eur Heart J 33:3070-3077. doi:10.1093/eurheartj/ehs265
80. Loubeyre C, Morice MC, Lefevre T et al (2002) A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. J Am Coll Cardiol 39:15-21 (Pubitemid 34059856)
81. DANish Study of Optimal Acute Treatment of Patients With STelevation Myocardial Infarction; ClinicalTrials.gov Identifier: NCT01435408)
82. Zhao CM, Yang XJ, Yang JH et al (2012) Effect of ischemic postconditioning on recovery of left ventricular contractile function after acute myocardial infarction. J Int Med Res 40(3):1082-1088
83. Luo W, Li B, Lin G et al (2008) Does cardioplegia leave room for postconditioning in paediatric cardiac surgery? Cardiol Young 18:282-287. doi:10.1017/S1047951108002072 (Pubitemid 351780775)
84. Thibault H, Piot C, Staat P et al (2008) Long-term benefit of postconditioning. Circulation 117(8):1037-1044. doi:10.1161/CIRCULATIONAHA.107. 729780
85. Luo W, Li B, Chen R et al (2008) Effect of ischemic postconditioning in adult valve replacement. Eur J Cardiothorac Surg 33(2):203-208
86. Ma XJ, Yin HJ, Guo CY et al (2012) Ischemic postconditioning through percutaneous transluminal coronary angioplasty in pigs: roles of PI3K activation. Coron Artery Dis 23(4):245-250. doi:10.1097/MCA.0b013e3283526a7d